Literature DB >> 2193015

Graft-versus-host disease.

G B Vogelsang1, J E Wagner.   

Abstract

Graft-versus-host disease (GVHD) is caused by immunologic recognition of the patient by the donor marrow graft after allogeneic bone marrow transplantation. Despite advances in understanding and new agents and methods to treat GVHD, the disease and complications related to it and its treatment are the principal causes of death after transplantation. This article reviews the pathogenesis, prediction, prophylaxis, and treatment of both acute and chronic GVHD.

Entities:  

Mesh：

Year:  1990        PMID： 2193015

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  6 in total

1.  Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.

Authors:  Nirali N Shah; Kristin Baird; Cynthia P Delbrook; Thomas A Fleisher; Mark E Kohler; Shakuntala Rampertaap; Kimberly Lemberg; Carolyn K Hurley; David E Kleiner; Melinda S Merchant; Stefania Pittaluga; Marianna Sabatino; David F Stroncek; Alan S Wayne; Hua Zhang; Terry J Fry; Crystal L Mackall
Journal:  Blood       Date:  2014-12-01       Impact factor: 22.113

2.  Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.

Authors:  Lori Wiener; Kristin Baird; Caroline Crum; Kimberly Powers; Paul Carpenter; K Scott Baker; Margaret L MacMillan; Eneida Nemecek; Jin-Shei Lai; Sandra A Mitchell; David A Jacobsohn
Journal:  Support Care Cancer       Date:  2014-02       Impact factor: 3.603

3.  Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.

Authors:  Kristin Baird; Terry J Fry; Seth M Steinberg; Michael R Bishop; Daniel H Fowler; Cynthia P Delbrook; Jennifer L Humphrey; Alison Rager; Kelly Richards; Alan S Wayne; Crystal L Mackall
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-05       Impact factor: 5.742

4.  Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.

Authors:  S Shenoy; K Desch; B Duffy; P Thorson; T Mohanakumar
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

5.  High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases.

Authors:  C H McDonough; D A Jacobsohn; G B Vogelsang; S J Noga; A R Chen
Journal:  Bone Marrow Transplant       Date:  2003-06       Impact factor: 5.483

6.  Experimental repetitive mild traumatic brain injury induces deficits in trabecular bone microarchitecture and strength in mice.

Authors:  Chandrasekhar Kesavan; Nikita M Bajwa; Heather Watt; Subburaman Mohan
Journal:  Bone Res       Date:  2017-12-19       Impact factor: 13.567
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.